Lamotrigine Phase III Study in Bipolar I Disorder

NCT01602510 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

265

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Lamotrigine
DRUG: Placebo

Sponsor

GlaxoSmithKline